4 Recruiting Studies Using Arsenic Trioxide
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Arsenic Trioxide
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
📍 Children's Hospital of Alabama — Birmingham, Alabama
Acute Promyelocytic Leukemia With t(15;17)(q24.1;q21.2); PML-RARA
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic
ATRA and SDK002 in Combination With Chemotherapy and Anti-PD-1 Inhibitor in Patients With Advanced Pancreatic Ductal Adenocarcinoma.
📍 Verspeeten Family Cancer Centre — London, Ontario
Advanced Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔ 🟡 Not Yet Recruiting Phase1 💊 Investigational Drug / Biologic
Arsenic Trioxide to Prevent Relapse in Patients Undergoing Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome
📍 University of Michigan Rogel Cancer Center — Ann Arbor, Michigan
Acute Myeloid Leukemia
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Tretinoin and Arsenic Trioxide With or Without Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated Acute Promyelocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Acute Promyelocytic Leukemia With PML-RARA
View Study & Checklist ➔